On Aug. 29, the Centers for Medicare & Medicaid Services (“CMS”) issued the inaugural list of drugs selected for price setting under the Inflation Reduction Act of 2022 (IRA).[1] Those selected drugs ...
The 10 drugs, spanning disease states from diabetes to heart failure to rheumatoid arthritis, cost Medicare enrollees a total of $3.4 billion in out-of-pocket costs in 2022. As required by the ...
These drugs represent the top 10 “qualifying single source” drugs with the highest expenditures under the Medicare Part D program. “Qualifying drugs” include small molecule drug products that were ...
The Centers for Medicare & Medicaid Services (CMS) released a list of prescription drugs it hopes to include in its new Medicare $2 Drug List Model, the agency announced Wednesday. Designed to limit ...
(The Hill) – The Trump administration on Tuesday announced the 15 drugs selected to participate in the newest round of the Medicare Drug Price Negotiation Program, including the high-cost medications ...
CMS released a preliminary list of 101 generic drugs for its Medicare $2 Drug List Model, which aims to cap out-of-pocket costs at $2 per month for select medications. The initial list includes common ...
The Medicare Inpatient Only (IPO) list details the procedures that Medicare will cover in an inpatient setting. The Centers for Medicare & Medicaid Services (CMS) releases the IPO list each year. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results